Login to Your Account



Pharma: Other News To Note


Friday, December 21, 2012
• Boehringer Ingelheim GmbH, of Ingelheim, Germany, said U.S. prescribing information for Pradaxa (dabigatran etexilate mesylate) capsules was updated to include a contraindication related to use in patients with mechanical prosthetic heart valve replacement.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription